"Forest Labs Gedeon Richter plan 2012 filing cariprazine" Channels 
BioPortfolio's Channels offers visitors a single point of access to life science and healthcare subjects, technologies, products and services. For example ImmTAC developed by Immunocore, PolyXen developed by Xenetic Biosciences. Each dedicated Channel web page provides highly specific information sourced from BioPortfolio's unique collection of databases - news stories, corporate directory, clinical trials, medical and scientific information.
Organizations can request specific channel pages to be created to promote their products, technologies, research tools and services. BioPortfolio makes a nominal charge of between $40 to $50 per web page published. Each bespoke Channel page is managed by the registered member who can edit and amend over the 12 month subscription period. To start publishing content on BioPortfolio's Channels open http://www.bioportfolio.net/report/23346-biochannel-publish-content-on-products-technologies.html
Interested? Contact priority@bioportfolio.com
Showing "Forest Labs Gedeon Richter plan 2012 filing cariprazine" Channels, all 18
The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ~ 57,747 Sanofi ~ 46,454 Novartis&n...
Omsk hemorrhagic fever and Kyasanur Forest disease
Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of biotech and pharma companies developing new therapies.
Macitentan (Opsumit®) is a novel dual endothelin receptor antagonist (ERA) that resulted from a tailored drug discovery process with the target to develop an ERA optimized for efficacy and safety [2]. Macitentan has a number of potentially key benefi...
Alto Marketing - specialist healthcare and life science communications consultancy
Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy. With extensive experience of worldwide marketing in sectors including (bio)pharmaceutical, diagnostics and medical devices, Alt...
Abilify (Aripiprazole) is an atypical antipsychotic produced by Bristol-Myers Squibb Company, with annual sales of $3m, ranking it 6th in the world for annual sales. Abilify is prescribed in addition to other anti-depressants for the treatment of...
Located in the north-east corner of the USA, Massachusetts, has the third highest GDP of any state in America and is also a hotspot for the biotechnology industry. In addition to the globally renowned MIT, many other academic institutions and companies c...
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the entire immune system, and thus restore immunological bal...
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...
Coronavirus were first identified in the 1960s, and were named after the crown-like projections on the surface of the virus. They cause respiratory infections in both humans and animals. Coronaviruses are a large family of viruses that includes viruses...
Sequencing platforms in diagnostic laboratories may aid both patient management by detecting resistance associated mutations, and public health measures, by determining phylogenetic relationships between infections from different patients. Current platfo...
Therapies targeting TNF have already demonstrated efficacy across a wide range of inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondulitis, psoriasis and Crohn’s disease. The target market for Kin...
SERAPHIN - STUDY WITH ENDOTHELIN RECEPTOR ANTAGONIST IN PULMONARY ARTERIAL HYPERTENSION TO IMPROVE CLINICAL OUTCOME. SERAPHIN (Study with an Endothelin Receptor Antagonist in Pulmonary arterial Hypertension to Im...
What is new in prostate cancer research and development?
Key research areas in relation to Prostate Cancer are discussed below. Brief descriptions are supported by hyperlinks to the most relevant research papers and current affairs news reports and blog postings - follow these links for more detailed inf...
The pharmaceutical industry is massive, both in range of products and in financial values. These are the top 200 drugs (ranked in descending order according to total sales in 20010, $), and the companies that make them. To find out more about the Compa...
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Over half of Bipolar cases develops before the age of 25. Bipolar...
Tumor markers are substances produced by tumor cells or by other cells of the body in response to cancer or certain benign (noncancerous) conditions. These substances can be found in the blood, in the urine, in the tumor tissue, or in other tissues. Diff...
Technical background: HUMIRA is a tumor necrosis factor (TNF) blocker - further details can be viewed: Tumor Necrosis Factor TNF Cytokine Tumour Necrosis Factor (TNF) Mechanism of Action: Adalimumab is a recombinant human anti-TNF mono...
